These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 24528496)

  • 1. An analytical framework for assessing drug and therapeutics committee structure and work processes in tertiary Brazilian hospitals.
    Lima-Dellamora Eda C; Caetano R; Gustafsson LL; Godman BB; Patterson K; Osorio-de-Castro CG
    Basic Clin Pharmacol Toxicol; 2014 Sep; 115(3):268-76. PubMed ID: 24528496
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Perspectives on Drug and Therapeutics Committee policy implementation.
    Tan EL; Day RO; Brien JA
    Res Social Adm Pharm; 2005 Dec; 1(4):526-45. PubMed ID: 17138494
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Analysis of the selection process for new drugs in a tertiary hospital 2004-2007].
    Alfaro-Lara ER; Galván-Banqueri M; Prado-Mel E; Santos-Ramos B; Varela-Aguilar JM; Torelló-Iserte J; Castellano Zurera MM; Bautista Paloma FJ
    Farm Hosp; 2010; 34(2):76-84. PubMed ID: 20304366
    [TBL] [Abstract][Full Text] [Related]  

  • 4. What constitutes evidence in hospital new drug decision making?
    Jenkings KN; Barber N
    Soc Sci Med; 2004 May; 58(9):1757-66. PubMed ID: 14990376
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Drug and therapeutics committees: the relationships among structure, function, and effectiveness.
    Plumridge RJ; Stoelwinder JU; Rucker TD
    Hosp Pharm; 1993 Jun; 28(6):492-3, 496-8, 508. PubMed ID: 10126453
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inter-role relationships in hospital-based pharmacy and therapeutics committee decision making.
    Bagozzi RP; Ascione FJ; Mannebach MA
    J Health Psychol; 2005 Jan; 10(1):45-64. PubMed ID: 15576500
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Improving the performance of Drug and Therapeutics Committees in hospitals--a quasi-experimental study in Laos.
    Vang C; Tomson G; Kounnavong S; Southammavong T; Phanyanouvong A; Johansson R; Eriksson B; Wahlstrom R
    Eur J Clin Pharmacol; 2006 Jan; 62(1):57-63. PubMed ID: 16372173
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Literature review on the structure and operation of Pharmacy and Therapeutics Committees.
    Durán-García E; Santos-Ramos B; Puigventos-Latorre F; Ortega A
    Int J Clin Pharm; 2011 Jun; 33(3):475-83. PubMed ID: 21416393
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Challenges of a P & T Committee in a community teaching hospital.
    Cooke DH; Kessler J
    Hosp Formul; 1990 Aug; 25(8):878-82, 886. PubMed ID: 10105706
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Drug and therapeutics committees in Danish hospitals: a survey of organization, activities and drug selection procedures.
    Plet HT; Hallas J; Nielsen GS; Kjeldsen LJ
    Basic Clin Pharmacol Toxicol; 2013 Apr; 112(4):264-9. PubMed ID: 23107106
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Drug and Therapeutics Committees in Australia: expected and actual performance.
    Weekes LM; Brooks C
    Br J Clin Pharmacol; 1996 Nov; 42(5):551-7. PubMed ID: 8951185
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Diffusion of innovation II: Formulary acceptance rates of new drugs in teaching and non-teaching British Columbia hospitals--a drug development perspective.
    D'Sa MM; Hill DS; Stratton TP
    Can J Hosp Pharm; 1995 Feb; 48(1):7-15. PubMed ID: 10141063
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prioritising drug and therapeutics committee (DTC) decisions: a national survey.
    Tan EL; Day RO; Brien JA
    Pharm World Sci; 2007 Apr; 29(2):90-6. PubMed ID: 17187221
    [TBL] [Abstract][Full Text] [Related]  

  • 14. P & T Committee roundtable discussion: Eastern region. Part I.
    Fine DJ; Guild RT; Kleinmann K; Kupersmith J
    Hosp Formul; 1984 Jun; 19(6):469-72, 475-6. PubMed ID: 10266565
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Drug and Therapeutics (D & T) committees in Dutch hospitals: a nation-wide survey of structure, activities, and drug selection procedures.
    Fijn R; Brouwers JR; Knaap RJ; De Jong-Van Den Berg LT
    Br J Clin Pharmacol; 1999 Aug; 48(2):239-46. PubMed ID: 10417503
    [TBL] [Abstract][Full Text] [Related]  

  • 16. P & T Committee roundtable discussion: Great Lakes region. Part II.
    McQuone M; Salberg DJ; Weintraub M
    Hosp Formul; 1984 Feb; 19(2):129-32, 136-8, 147-8. PubMed ID: 10264742
    [TBL] [Abstract][Full Text] [Related]  

  • 17. "There are ways … drug companies will get into DTC decisions": How Australian drug and therapeutics committees address pharmaceutical industry influence.
    Parker L; Bennett A; Mintzes B; Grundy Q; Fabbri A; Karanges EA; Bero L
    Br J Clin Pharmacol; 2021 May; 87(5):2341-2353. PubMed ID: 33129226
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The right drug, but from whose perspective? A framework for analysing the structure and activities of drug and therapeutics committees.
    Hoffmann M
    Eur J Clin Pharmacol; 2013 May; 69 Suppl 1(Suppl 1):79-87. PubMed ID: 23640192
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Improving pharmacy and therapeutics committee operations.
    Cohen MR; Klapp D; Miller KB; Shaffer VL; Slotfeldt M; Miller DE
    Am J Hosp Pharm; 1984 Sep; 41(9):1767-77. PubMed ID: 6496511
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Drug and therapeutics committees in Nigeria: evaluation of scope and functionality.
    Fadare JO; Ogunleye O; Obiako R; Orubu S; Enwere O; Ajemigbitse AA; Meyer JC; Enato E; Massele A; Godman B; Gustafsson LL
    Expert Rev Clin Pharmacol; 2018 Dec; 11(12):1255-1262. PubMed ID: 30451035
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.